Pharmaceutical Technology

MARCH 6, 2023

Currently, most drugs being investigated for their healthy aging or anti-aging properties are being repurposed from readily accessible FDA-approved drugs. Barzilai hopes that the well-established profile of the drug may allow the FDA to accept the trial more easily and then other aging-related studies can follow.

FDA 145

FDA Pharmaceutical Prospecting Medicine 145

Pharmaceutical Technology

DECEMBER 21, 2022

According to GlobalData, global AI revenues in the pharmaceutical, medical, and healthcare sectors are expected to reach almost $21 billion by 2025. GlobalData is the parent company of Pharmaceutical Technology. FDA and EMA action.

Pharma 140

Pharma Pharmaceutical Medicine Government 140

Pharmaceutical Technology

APRIL 12, 2023

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. Globally, non-human primates make up a relatively small percentage of the animals used in research. The ABPI points to the FDA in the US as an example.

Pharma 98

Pharma Food and Drug Administration Safety Medicine 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97